SLC25A6 results significantly upregulated in 7 cancer tissues and significantly downregulated in 2 cancer tissues, out of the 21 “tumor vs. normal” tissue pairs (Figure 1, bottom panel). This evidence concerns the gene SLC25A6 and cancer.